secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioNexus Gene Lab Corp (BGLC)
CIK:        0001737523
Form:       8-K
Filed at:   2022-08-15T23:59:59+00:00
Accession:  0001477932-22-006086
Event type: leadership
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Bionexus Gene Lab replaces Chairman, CEO, and President in leadership reshuffle
-------------------------------------------------------------------------------

- Chairman Soo Kow Lai, CEO Chan Chong Wong, and President Chi Yuen Leong resigned effective Aug 12, 2022; no disagreement cited.
- Yeat Min Fong appointed Chairman, Sook Keng Yeoh CEO, Yee Meng Wong President, effective Aug 9, 2022.
- Each new officer receives $12,000 annual salary and 25,000 common shares under employment agreements.
- Fong has 15+ years in medical industry; Yeoh 41 years in management; Wong biochem background with 10+ years research.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1737523/000147793222006086/0001477932-22-006086-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1737523/000147793222006086/bglc_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-22-006086

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer